Market Research Report
Surgical Dressing Market Analysis by Product (Primary Dressing, Secondary Dressing, Others), By End-use (Hospital, Specialty Clinics, Home Healthcare, Ambulatory Centers), By Application, And Segment Forecasts, 2014 - 2025
|Published by||Grand View Research, Inc.||Product code||557192|
|Published||Content info||120 Pages
Delivery time: 2-3 business days
|Surgical Dressing Market Analysis by Product (Primary Dressing, Secondary Dressing, Others), By End-use (Hospital, Specialty Clinics, Home Healthcare, Ambulatory Centers), By Application, And Segment Forecasts, 2014 - 2025|
|Published: August 9, 2017||Content info: 120 Pages||
The global surgical dressing market is expected to reach USD 5.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 5.6% over the forecast period, owing to increasing organ transplant surgeries, increasing disease burden of lifestyle disorders and widened range and number of Ambulatory Surgical Centers (ASC).
Globally there were 126,670 organ transplant surgeries in 2015, which is approximately 15.0% higher than transplants in 2000, according to the Global Observatory on Donations and Transplantation (GODT) database. This exponential increase in the number of organ transplant surgeries is expected to increase the demand for these products in this vertical.
Another key driver for this market is the increased disease burden of Cardiovascular Diseases (CVD) and the resultant surgeries for the treatment or management of the disease. It was estimated by the American Heart Association (AHA) that 92.1 million adults in the U.S. would suffer from at least one type of CVD by 2017.
ASC conduct surgical procedures related to pain management, urology, orthopedics, restorative, reconstructive or alternative plastic surgeries and Gastro Intestinal (GI) related surgeries. Thus, rising volume and range of ASC is expected to increase the demand for this industry.
The key players include Medline Industries, Inc. Smith & Nephew, Advancis Medical, Acelity, Medtronic, Alliqua Biomedical, Inc., 3M, Coloplast, ConvaTec, Inc., Molnlycke Health Care AB.
The key strategic initiatives include new product launches, acquisitions and mergers, and collaborations.